Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of Cell-free Fetal DNA Concentration in the Maternal Plasma for Abnormal Placental Invasion in Cases of Placenta Previa.

NCT03638024 is registered in ClinicalTrials.gov with Ain Shams Maternity Hospital as lead sponsor.

NCT NCT03638024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03638024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of Cell-free Fetal DNA Concentration in the Maternal Plasma for Abnormal Placental Invasion in Cases of Placenta Previa.
Lead sponsor
Ain Shams Maternity Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2018
Completion date
April 3, 2019
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

placenta accreta, placenta increta, placenta percreta, placenta previa